Incidence, trends and risk factors for obstetric massive blood transfusion in China from 2012 to 2019: an

Yanxia Xie1, Juan Liang1,2, Yi Mu1

  • 1National Office for Maternal and Child Health Surveillance of China, Sichuan University West China Second University Hospital, Chengdu, Sichuan, China.

BMJ Open
|September 30, 2021
PubMed

Insights

Obstetric massive blood transfusion (MBT) incidence increased in China from 2012-2019, linked to factors like uterine atony and advanced maternal age. However, hysterectomy and maternal mortality rates decreased among MBT patients.

Area of Science:

  • Obstetrics and Gynecology
  • Transfusion Medicine
  • Public Health Surveillance

Background:

  • Massive blood transfusion (MBT) in obstetrics is a critical indicator of severe maternal morbidity.
  • Understanding the epidemiology and risk factors of obstetric MBT is crucial for improving maternal outcomes.
  • China's National Maternal Near Miss Surveillance System (NMNMSS) provides valuable data for national health studies.

Purpose of the Study:

  • To determine the incidence and trends of obstetric massive blood transfusion (MBT) in China from 2012 to 2019.
  • To identify the key risk factors and associated conditions leading to obstetric MBT.
  • To evaluate the clinical outcomes, including hysterectomy and maternal mortality, for women undergoing MBT.

Main Methods:

  • An observational study utilizing data from China's National Maternal Near Miss Surveillance System (NMNMSS) between 2012 and 2019.
  • Inclusion of 11,667,406 hospitalised pregnancies.
  • Analysis of MBT incidence (≥5 units RBC or ≥1000 mL whole blood per 10,000 maternities), trends, risk factors, and outcomes (hysterectomy, maternal mortality ratio).

Main Results:

  • The incidence of obstetric MBT increased from 14.03 to 29.59 per 10,000 maternities between 2012 and 2019 (p<0.001).
  • Key associated factors included amniotic fluid embolism, uterine atony, abnormal placenta, severe anemia, and advanced maternal age.
  • Hysterectomy incidence decreased from 25.07% to 9.92%, and in-hospital maternal mortality ratio declined from 21.41‰ to 7.48‰ among MBT patients (p<0.001).

Conclusions:

  • Obstetric MBT incidence is rising in China, necessitating targeted interventions.
  • Focusing on antenatal education, evidence-based transfusion practices, and managing high-risk conditions like uterine atony and severe anemia is vital.
  • Despite increasing MBT incidence, clinical outcomes have improved, indicated by reduced hysterectomy rates and maternal mortality.
Abstract